<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although intravenous delivery of mesenchymal stem cells (MSCs) prepared from adult bone marrow reduces infarction size and ameliorates functional deficits in rat middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> models, there are few reports of MSC treatment in global <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We utilized a global <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> model induced by arresting the heart with a combination of <z:hpo ids='HP_0011106'>hypovolemia</z:hpo> and intracardiac injections of a cold <z:chebi fb="11" ids="32588">potassium chloride</z:chebi> solution in order to study the potential therapeutic benefits of human mesenchymal stem cells (hMSCs) on global <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>hMSCs were intravenously injected into the rats 3 h after resuscitation from <z:hpo ids='HP_0001695'>cardiac arrest</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The effects on structural and functional outcome of hMSC were assessed at 5 h and 1, 3, and 7 days using magnetic resonance spectroscopy (MRS), histology, and cognitive functional analysis </plain></SENT>
<SENT sid="4" pm="."><plain>Intravenous delivery of hMSCs reduced the Lac/Cr ratios, nuclear DNA fragmentation, <z:hpo ids='HP_0002529'>neuronal loss</z:hpo>, and elicited functional improvement compared with the control sham group </plain></SENT>
<SENT sid="5" pm="."><plain>Enzyme-linked immunosorbent assay (ELISA) of the hippocampus revealed an increase in BDNF in hMSC-treated group </plain></SENT>
<SENT sid="6" pm="."><plain>These data suggest that intravenous delivery of hMSC may have a therapeutic effect in global <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>